The FASEB Journal · 2019 · 27 citations · 26 references
Life SciencesImmunologyMolecular BiologyAutoimmunityCellular ImmunologySignal TransductionAutoimmune DiseasesCytokine BiologyImmune Cell SignalingRegulation Of AutoimmunitySystemic Lupus ErythematosusT Cell BiologyAutoimmune Effector T Cell ResponsesInterleukin-17 PathwayOrphan Nuclear ReceptorsRetinoic Acid Receptor SignalingSystemic Lupus Erythematosus AssociationsTh17 ResponsesTransgenic MiceTransgenic Mouse Models
ABSTRACT The cytokine IL‐17A plays critical roles in the pathogenesis of autoimmune diseases. The frequencies of MAP kinase kinase kinase kinase 3 [also named germinal center kinase–like kinase (GLK)]‐overexpressing T cells are correlated with disease severity of systemic lupus erythematosus (SLE). T‐cell–specific GLK‐transgenic mice develop spontaneous autoimmune responses through IL‐17A. GLK signaling selectively stimulates IL‐17A production in murine T cells through inducing aryl hydrocarbon receptor (AhR)–retinoic acid receptor–related orphan nuclear receptor‐³t (ROR‐³t) complex formation. Here, we investigated whether GLK‐induced AhR–ROR‐³t complex in T cells is a therapeutic target for human SLE. The population of GLK + IL‐17A + T cells was enhanced in the peripheral blood from patients with SLE compared with that of healthy controls using flow cytometry. The receiver operating characteristic curve analysis showed that increased GLK + IL‐17A + T‐cell population in peripheral blood reflected an active stage of SLE. In addition, peripheral blood T cells from patients with SLE displayed induction of ROR‐³t phosphorylation and the AhR‐ROR‐³t (and AhR–phosphorylated ROR‐³t) complex. Moreover, we identified a small‐molecule inhibitor, verteporfin, that inhibited GLK kinase activity and AhR–ROR‐³t interaction. The small‐molecule inhibitor verteporfin suppressed the disease severity in autoimmune mouse models and IL‐17A production in T cells from patients with SLE. Collectively, the GLK‐induced AhR‐ROR‐³t (and AhR–phosphorylated ROR‐³t) complex is a therapeutic target for the GLK high IL‐17A high subpopulation of human patients with SLE.—Chuang, H.‐C, Chen, Y.‐M., Chen, M.‐H., Hung, W.‐T., Yang, H.‐Y., Tseng, Y.‐H., Tan, T.‐H. AhR‐ROR‐³t complex is a therapeutic target for MAP4K3/GLK high IL‐17A high subpopulation of systemic lupus erythematosus. FA8EB J. 33, 11469–11480 (2019). www.fasebj.org
26
Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
Francisco J. Quintana, Alexandre S. Basso, Antonio Iglesias et al. · Nature · 2008 · 1.8K citations
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Marc Veldhoen, Keiji Hirota, Astrid M. Westendorf et al. · Nature · 2008 · 1.6K citations · Full text
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells
Roza Nurieva, Xuexian O. Yang, Gustavo Martínez et al. · Nature · 2007 · 1.5K citations